Godavari Drugs Ltd

Godavari Drugs Annual General Meeting

Godavari Drugs held its 38th Annual General Meeting on September 25, 2026, via video conferencing. Shareholders approved financial statements, director re-appointment, and object clause alteration.

Godavari Drugs Annual General Meeting

Godavari Drugs Limited will close its register of members and share transfer books from September 19 to September 25, 2026, for its 38th Annual General Meeting.

Godavari Drugs Board Meeting Outcome

Godavari Drugs approved altering its Memorandum of Association to add a nutraceuticals business object. A revised notice for the 38th AGM was also approved.

Godavari Drugs Capital Structure Change

Godavari Drugs Limited allotted 7,86,690 equity shares to the promoter category following warrant conversion. The company received Rs. 5.25 Crore, representing the final 75% payment.

Value

₹5.25 Cr

Godavari Drugs Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 10.0% YoY

Godavari Drugs Ltd reported revenue from operations of ₹28 Cr (+17.6% YoY) and net profit of ₹1.1 Cr (+10.0% YoY) for Q1 FY27.

Key figure

Net profit ₹1.1 Cr · +10.0% YoY

Godavari Drugs Board Meeting Date

Godavari Drugs Limited has scheduled a board meeting for August 24, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026.

Godavari Drugs Other Announcement

Godavari Drugs Ltd filed its quarterly shareholding pattern as of June 30, 2026. The document provides a detailed breakdown of promoter and public holdings.